His primary scientific interests are in Genetics, Genome-wide association study, Internal medicine, Cancer and Single-nucleotide polymorphism. D. Timothy Bishop works mostly in the field of Genome-wide association study, limiting it down to topics relating to Allele and, in certain cases, Genetic linkage. He has researched Internal medicine in several fields, including Gastroenterology, Surgery and Oncology.
His Single-nucleotide polymorphism research is multidisciplinary, incorporating perspectives in Human genetics and Allele frequency. His Human genetics research incorporates elements of Polymorphism, Population stratification, Genome, Disease and CDKN2BAS. His CDKN2A research integrates issues from Hereditary Melanoma, Germline mutation and Melanoma.
His primary areas of investigation include Genetics, Internal medicine, Melanoma, Oncology and Genome-wide association study. His Genetics study is mostly concerned with Single-nucleotide polymorphism, Germline mutation, Gene, CDKN2A and Locus. His Single-nucleotide polymorphism research is multidisciplinary, incorporating perspectives in Allele and Polymorphism.
His Melanoma study combines topics in areas such as Mutation and Pathology. His study looks at the relationship between Oncology and topics such as Cohort, which overlap with Cohort study. His Genome-wide association study research includes elements of Linkage disequilibrium and Genetic association.
His primary areas of study are Internal medicine, Oncology, Colorectal cancer, Melanoma and Genome-wide association study. His work on Cancer, Lynch syndrome and Aspirin as part of general Internal medicine research is frequently linked to Mendelian randomization and Dependency, bridging the gap between disciplines. His biological study spans a wide range of topics, including Odds ratio, Relative risk, Proportional hazards model, Cohort and Candidate gene.
His studies deal with areas such as Epidemiology, Genetic risk, Case-control study, Genotype and Primary tumor as well as Colorectal cancer. His research in Melanoma intersects with topics in Germline mutation, Disease, Neuroblastoma RAS viral oncogene homolog and Immunotherapy. D. Timothy Bishop is investigating Genome-wide association study as part of his inquiry into Single-nucleotide polymorphism and Genetics.
Odds ratio, Internal medicine, Oncology, Melanoma and Case-control study are his primary areas of study. As part of the same scientific family, D. Timothy Bishop usually focuses on Odds ratio, concentrating on Confidence interval and intersecting with Single-nucleotide polymorphism, Breast cancer, Epidemiology of cancer, Mendelian Randomization Analysis and Epidemiology. His biological study deals with issues like Neuroblastoma RAS viral oncogene homolog, which deal with fields such as Missense mutation, Germline mutation, Hereditary Melanoma, Germline and CDKN2A.
His Missense mutation study introduces a deeper knowledge of Genetics. He interconnects Genome-wide association study, Cohort study, Colorectal cancer, Family history and Cohort in the investigation of issues within Case-control study. The Genome-wide association study study combines topics in areas such as Meta-analysis and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Paul R. Burton;David G. Clayton;Lon R. Cardon;Nick Craddock.
Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995))
Xifeng Wu;Yuanqing Ye;Lambertus A. Kiemeney;Patrick Sulem.
Nature Genetics (2009)
Genome-wide association study identifies eight loci associated with blood pressure
Christopher Newton-Cheh;Christopher Newton-Cheh;Toby Johnson;Toby Johnson;Vesela Gateva;Martin D. Tobin.
Nature Genetics (2009)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn;Anne Marie Gerdes;Finlay MacRae;Jukka Pekka Mecklin.
The Lancet (2011)
Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations
Sunil R. Lakhani;Jocelyne Jacquemier;John P Sloane;Barry A. Gusterson.
Journal of the National Cancer Institute (1998)
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types.
Thorunn Rafnar;Patrick Sulem;Simon N Stacey;Frank Geller.
Nature Genetics (2009)
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3
Ian P.M. Tomlinson;Emily Webb;Luis Carvajal-Carmona;Peter Broderick.
Nature Genetics (2008)
Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A
Sergey Nejentsev;Joanna M. M. Howson;Neil M. Walker;Jeffrey Szeszko.
Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma
D. Timothy Bishop;Florence Demenais;Alisa M. Goldstein;Wilma Bergman.
Journal of the National Cancer Institute (2002)
A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene: Implications for Presymptomatic Testing and Screening
Donna Shattuck Eidens;Melody Mcclure;Jacques Simard;Fernand Labrie.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: